Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor microenvironment remodeling, and ...

A new blood test profiles tumor microenvironment ecotypes via cell-free DNA methylation—correlating with biopsy findings and ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

In this session you will learn how spatial transcriptomics with single-cell resolution enable detailed cellular mapping of ...

Key opportunities in the Global Spatial Genomics and Transcriptomics Market include technological advancements in spatial ...

Longitudinal peripheral transcriptomics across 546 samples from 160 I-SPY2 patients captured dynamic immune engagement during neoadjuvant therapy, avoiding the temporal and spatial limitations of ...

Head and neck cancers display notable heterogeneity in their immune cell infiltrates, which reflect intricate spatial arrangements and dynamic networks of ...

AutoNorm™ adaptive amplification technology to lower throughput sequencing workflows. The system monitors each well in real time and stops amplification individually at a user defined endpoint, ...

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...

Management raised full-year guidance, with Dhingra stating, "We are raising our reported revenue guidance by $20 million... and now expect revenue of $4.52 billion to $4.62 billion" and "now expect ...

Spatial transcriptomics is revolutionizing the study of tissue architecture, cellular states, and tumor-immune interactions in clinical specimens. This presentation introduces the principles and ...

You will be redirected to our submission process. Cancer tumorigenesis is fundamentally driven by the profound dysregulation of gene regulatory networks (GRNs) and complex epigenetic alterations. With ...